Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. - Wikidata - wikimedia - TriplyDB

Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition.

Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition.

http://www.wikidata.org/entity/Q35558027

about

Suppression of breast tumor growth and metastasis by an engineered transcription factor Interaction of tumor cells with the microenvironment Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies Hedgehog Signaling in the Maintenance of Cancer Stem Cells The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment Positional variations in mammary gland development and cancer Withania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transition Potential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseases Preferential, enhanced breast cancer cell migration on biomimetic electrospun nanofiber 'cell highways'Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines.Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer.Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.Ascl2 knockdown results in tumor growth arrest by miRNA-302b-related inhibition of colon cancer progenitor cells.A systems biology approach reveals common metastatic pathways in osteosarcoma.P38/NF-κB/snail pathway is involved in caffeic acid-induced inhibition of cancer stem cells-like properties and migratory capacity in malignant human keratinocyte.Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-β/SMAD signaling.Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice.Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression Wnt/catenin signaling in adult stem cell physiology and disease.RNA-based TWIST1 inhibition via dendrimer complex to reduce breast cancer cell metastasis.An integrative meta-analysis of microRNAs in hepatocellular carcinoma.NOTCH decoys that selectively block DLL/NOTCH or JAG/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth.Bioengineering embryonic stem cell microenvironments for the study of breast cancer Tetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cells The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer Hedgehog pathway as a drug target: Smoothened inhibitors in development.Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy.Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin).Multifaceted leptin network: the molecular connection between obesity and breast cancer.Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway.Role of the microenvironment in ovarian cancer stem cell maintenance.Alteration of GLIS3 gene expression pattern in patients with breast cancer.Structure-based discovery of antagonists of nuclear receptor LRH-1.Induction of an EMT-like transformation and MET in vitro.Krüppel-like factor 8 promotes tumorigenic mammary stem cell induction by targeting miR-146a.Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells.

P2860

Q21135222-0ED6C601-0B9F-443D-807A-0205D550C4ED Q21245506-6FDEEADE-5600-44EA-BAD7-F06DC1EEBBC1 Q26765342-00290484-E87E-4F9A-95A1-AEA3DA5109BC Q26798191-6A7C337C-26B7-4C96-9938-CBED754F21CF Q26865458-DCB76F1D-7C06-4003-A01B-F130F8BE8695 Q27008355-4CBF7E37-6672-494A-A0F5-6DDCF1EAB19D Q27305726-C46520D8-8CE7-40FA-A520-83F9E95C55F3 Q28391383-749198F2-A9B6-4ED7-A09A-7D7C8B1FC31E Q30599338-EAA5936E-1EBA-4D52-8598-904B38CA49D4 Q33613560-8081E58D-9DC1-48C2-9858-D5FF4FF54B78 Q33737058-870A2979-A5BF-452E-96A3-35E1EC9A2D93 Q33757106-12F3E67C-60C7-4F4C-B394-3E2CF6D84BCD Q33759701-046F273C-2603-49B3-A918-C7E54BBEB261 Q33833666-DE67DBE2-7883-494B-B473-69269495CA82 Q33892801-BBFF124F-5ACA-4201-AFAA-44F3642E7991 Q34182315-0C7F3305-0D56-494E-9B83-BE91292924AD Q34284702-5ACE825C-80CD-4CD0-B7CE-236A66F8D919 Q34630179-629E3F3D-66F1-422B-AC82-ED0BDCD07785 Q34708273-366D13FC-1082-4D23-ACB1-4FF7E44BE28B Q34898828-06E724BE-4DEC-4CE9-86B8-F389EDB81A8D Q34924229-7E669E22-8811-4632-84C3-25117CB83F96 Q34959673-A5967EFC-B2B9-45BD-84F0-E7DAF3EF6A3E Q35119155-0EFDA0B4-9761-4471-AFD5-B2634A8AAB81 Q35171752-3F41A04D-FFFD-4816-872E-23F94AA60671 Q35581299-F9DEF860-37FF-4C3F-8330-83108507C880 Q35600151-82A5FFC5-8961-4E5E-B2FE-70B8F10B8B03 Q35781480-25C9DA69-EC02-4A48-A35F-4D8DAD1A7E06 Q35832308-6604CE7C-AB5C-46D1-8012-46B873F65B4A Q35885181-93D308B9-E395-43B4-A63B-3460883F961C Q35904534-8FE21C80-57D0-4801-8B6A-3AB0D8747D3D Q35977057-4021D2C3-9E7B-463B-AF70-C00549CDF3A6 Q36426509-C840C526-507C-48E3-A2C1-D3533FE09974 Q36561207-E8B597A6-2634-4766-9AFF-9E95455F65CD Q36562209-C6C4DA91-C6EC-4567-8E90-0BA41EFE2A0F Q36665179-3FEEE803-A20D-4DF9-A215-4E8A93C74A9B Q36749993-6D225BAE-C487-45BF-96F2-3C272220845F Q37000608-90166467-436F-4E61-8CE4-D6ABEBDE71BB Q37027886-8C2CC9BC-BCB6-4CA2-A081-26B22A4A5888 Q37096462-3B87A86B-B44F-4291-8971-59CACE6E7027 Q37299331-8500A77A-6142-40C7-A259-4CCAB3A578CC

P2860

Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition.

http://www.wikidata.org/entity/Q35558027

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Breast cancer growth and metas ...... ial-to-mesenchymal transition.

@ast

Breast cancer growth and metas ...... ial-to-mesenchymal transition.

@en

type

label

Breast cancer growth and metas ...... ial-to-mesenchymal transition.

@ast

Breast cancer growth and metas ...... ial-to-mesenchymal transition.

@en

prefLabel

Breast cancer growth and metas ...... ial-to-mesenchymal transition.

@ast

Breast cancer growth and metas ...... ial-to-mesenchymal transition.

@en

P1433

Q35558027-392284ED-3070-4C3D-BBF6-AEEB0A358AEE

P1476

Q35558027-88FCD6BD-6CC2-436B-B616-6D3958DD2CE5

P2093

Q35558027-C1518F34-BA82-49F3-BA58-61B9770C822A

Q35558027-CA9FB2EC-BDE6-4089-B918-A69D04925D25

Q35558027-E81F98E2-ABED-40FB-A49A-D07EFBA395B0

P2860

Q35558027-016686B6-80EB-47F0-A597-4711D48EFB0A

Q35558027-02CB6DC3-5970-4C7A-8EE8-428094188D52

Q35558027-06E185A4-1CE4-445F-8876-FBA223C46764

Q35558027-08EA9D1E-B2A7-424E-B799-1919A3E7898B

Q35558027-0AF2D1D4-4AC5-4C87-BFCA-A6966346F18D

Q35558027-0C93B52A-D4B2-49CB-BC80-05AA4C2C2FD3

Q35558027-0D6405B2-456D-48CB-BB15-EE838EFDAFE5

Q35558027-0D715991-2659-44D6-B693-6F36AF4CB6B1

Q35558027-155ED912-C1AD-4D62-9227-97FC1A8101FA

Q35558027-1672405E-AC41-4595-98E2-F8690F6FE810

P2888

Q35558027-2A6E22C0-D8DD-4B37-9BA4-FF66DAF1C99A

P304

Q35558027-2514C48A-D3EA-4B24-AB1E-CEB5AF6AF781

P31

Q35558027-64C2DCA4-13FB-42E5-9662-DD597CF38BB6

Q35558027-A94799A5-A31E-495D-B3FD-96BB03D7A565

P356

Q35558027-92A8D436-3988-49D0-A3F3-94F59F5CF6A1

P433

Q35558027-7F2961CD-3171-4B49-8B93-C6B061E5BF65

P478

Q35558027-00092318-89C0-4566-96B8-365C27C6163A

P577

Q35558027-86BF3D62-904C-43DF-80D6-602C71898668

P5875

Q35558027-EF970D86-9B4E-4B9B-8B34-4CCA055F4422

P6179

Q35558027-C166625C-6F28-43AE-B678-36E1B241BE32

P698

Q35558027-93A86D15-1CFA-4CAA-8D8C-1772318F0267

P921

Q35558027-5E478501-6456-4763-A4C7-EC4701918A56

Q35558027-6BE0D347-780A-4401-BA68-ACAAF35CCE8D

Q35558027-76ECFA05-350E-474A-9A87-A487019BF98A

Q35558027-E54BAF2B-30F6-4D6F-BB03-F601DA6C2A6F

P932

Q35558027-0F016D26-EED7-45B8-8055-8B4443854337

P356

P1433

Breast Cancer Research

P1476

Breast cancer growth and metas ...... ial-to-mesenchymal transition.

@en

P2093

Naoko Takebe

http://www.w3.org/2001/XMLSchema#string

Ronald Q Warren

http://www.w3.org/2001/XMLSchema#string

S Percy Ivy

http://www.w3.org/2001/XMLSchema#string

P2860

A multidrug resistance transporter from human MCF-7 breast cancer cells

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

MicroRNAs: target recognition and regulatory functions

The epithelial-mesenchymal transition generates cells with properties of stem cells

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis

Prospective identification of tumorigenic breast cancer cells

E-cadherin expression in primary carcinomas of the breast and its distant metastases

Mapping sonic hedgehog-receptor interactions by steric interference

P2888

P304

211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2876

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51218323

http://www.w3.org/2001/XMLSchema#string

P6179

1042870647

http://www.w3.org/2001/XMLSchema#string

P698

21672282

http://www.w3.org/2001/XMLSchema#string

P921

breast neoplasm

P932

3218933

http://www.w3.org/2001/XMLSchema#string